Skip to content
10-K

Annual Report

ANI PHARMACEUTICALS INC ANIP

0001023024-26-000014

← back to feed
Filed
Feb 27, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 21.23M sh
Shares Diluted FY 2025 · Dec 31, 2024 19.32M sh
Shares Diluted FY 2025 · Dec 31, 2023 18.19M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $12.21M
Stock Repurchased FY 2025 · Dec 31, 2024 $10.96M
Stock Repurchased FY 2025 · Dec 31, 2023 $4.99M
Dividends Paid FY 2025 · Dec 31, 2025 $1.16M
Dividends Paid FY 2025 · Dec 31, 2024 $1.63M
Dividends Paid FY 2025 · Dec 31, 2023 $1.63M
Capex FY 2025 · Dec 31, 2025 $13.84M
Capex FY 2025 · Dec 31, 2024 $16.24M
Capex FY 2025 · Dec 31, 2023 $8.87M
Operating Cash Flow FY 2025 · Dec 31, 2025 $185.23M
Operating Cash Flow FY 2025 · Dec 31, 2024 $64.02M
Operating Cash Flow FY 2025 · Dec 31, 2023 $118.96M
Long Term Debt FY 2025 · Dec 31, 2025 $291.84M
Long Term Debt FY 2025 · Dec 31, 2024 $309.11M
Short Term Debt FY 2025 · Dec 31, 2025 $17.27M
Short Term Debt FY 2025 · Dec 31, 2024 $9.17M
Cash And Equivalents FY 2025 · Dec 31, 2025 $285.59M
Cash And Equivalents FY 2025 · Dec 31, 2024 $144.86M
Cash And Equivalents FY 2025 · Dec 31, 2023 $221.12M
Cash And Equivalents FY 2025 · Dec 31, 2022 $48.23M
Stockholders Equity FY 2025 · Dec 31, 2025 $540.72M
Stockholders Equity FY 2025 · Dec 31, 2024 $403.68M
Current Liabilities FY 2025 · Dec 31, 2025 $278.11M
Current Liabilities restated FY 2025 · Dec 31, 2024 $194.45M
Total Liabilities FY 2025 · Dec 31, 2025 $899.65M
Total Liabilities restated FY 2025 · Dec 31, 2024 $855.94M
Current Assets FY 2025 · Dec 31, 2025 $753.12M
Current Assets restated FY 2025 · Dec 31, 2024 $528.46M
Total Assets FY 2025 · Dec 31, 2025 $1.44B
Total Assets restated FY 2025 · Dec 31, 2024 $1.28B
Eps Diluted FY 2025 · Dec 31, 2025 $3.32
Eps Diluted FY 2025 · Dec 31, 2024 −$1.04
Eps Diluted FY 2025 · Dec 31, 2023 $0.85
Eps Basic FY 2025 · Dec 31, 2025 $3.50
Eps Basic FY 2025 · Dec 31, 2024 −$1.04
Eps Basic FY 2025 · Dec 31, 2023 $0.86
Sga Expense FY 2025 · Dec 31, 2025 $317.75M
Sga Expense FY 2025 · Dec 31, 2024 $249.64M
Sga Expense FY 2025 · Dec 31, 2023 $161.7M
Rd Expense FY 2025 · Dec 31, 2025 $51.66M
Rd Expense FY 2025 · Dec 31, 2024 $44.58M
Rd Expense FY 2025 · Dec 31, 2023 $34.29M
Net Income FY 2025 · Dec 31, 2025 $78.34M
Net Income FY 2025 · Dec 31, 2024 −$18.52M
Net Income FY 2025 · Dec 31, 2023 $18.78M
Operating Income FY 2025 · Dec 31, 2025 $111.09M
Operating Income FY 2025 · Dec 31, 2024 $584K
Operating Income FY 2025 · Dec 31, 2023 $46.97M
Revenue FY 2025 · Dec 31, 2025 $883.37M
Revenue FY 2025 · Dec 31, 2024 $614.38M
Revenue FY 2025 · Dec 31, 2023 $486.82M